Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Wednesday, 9th August, 2017 at the Registered Office of the Company at Ajanta House, Charkop, Kandivli (West), Mumbai - 400 067, to consider and approve the Unaudited consolidated and standalone Financial Results of the Company for the first quarter ended 30th June, 2017. Further, pursuant to the Ajanta’s Code of Conduct for of Insiders, the Trading Window for dealing in the shares of the Company shall remain closed for the Designated persons, from the close of business hours of Monday, 31st July, 2017. The trading window will open 48 hours after the announcement of results.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: